Journals / Mikrobiyoloji Bülteni / 2007 / Cilt: 41 - Sayı: 2

Evaluation of the relationship between Candida albicans 25S intron genotypes and antifungal susceptibilities

Candida albicans 25S intron genotipleri ile antifungal duyarlılıkları arsındaki ilişkinin araştırılması

Pages
245–251
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

As a result, in order to clarify the resistance mechanisms of different genotypes of C.albicans isolates, more sophisticated and large-scale studies should be performed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Due to the increase in the number of immunosuppressive patients, an increase in the frequency of Candida albicans infections is recorded during the recent years.
📊
Key Findings & Data:C.albicans strains can be grouped into three genotypes (genotypes A, B and C) by 25S intron analysis according to the presence of a transposable group-1 intron.
💡
Conclusion & Impact:As a result, in order to clarify the resistance mechanisms of different genotypes of C.albicans isolates, more sophisticated and large-scale studies should be performed.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:İlaç direnci · fungal · Genom

Abstract

Due to the increase in the number of immunosuppressive patients, an increase in the frequency of Candida albicans infections is recorded during the recent years. C.albicans strains can be grouped into three genotypes (genotypes A, B and C) by 25S intron analysis according to the presence of a transposable group-1 intron. Genotype A isolates were found to be associated with increased resistance to flucytosine. The aim of this study was to determine the genotypic distribution of C.albicans isolates and investigate the relationship between the genotypes and antifungal susceptibility patterns. Seventy clinical C.albicans isolates were included in the study. The strains were identified by API ID 32C (bioMerieux, France), and antifungal susceptibilities were determined by ATB Fungus 2 (bioMerieux, France) system. Following DNA extraction frorrUhe isolates, polymerase chain reaction (PCR) was performed as indicated in the literature. The genotypes were determined according to the size of the amplified PCR product. For the statistical analysis of the relationship between the genotypes and antifungal susceptibility patterns, Pearson's khi square and Fisher's exact tests were performed. Among the 70 strains investigated, 35 (50%) were found as genotype A, nine (12.9%) were genotype B and 26 (37.1%) were genotype C. Nystatin, miconazole and ketoconazole susceptibilities were significantly different among the genotypes, genotype B being more resistant to these agents (p values were 0.032, 0.035 and 0.035, respectively). When the susceptibility of the strains were compared according to the presence of the transposable intron, no significant difference was observed. There was also no statistically significant difference between the genotype distribution of the isolates and flucytosine, amphotericin B and econazole susceptibilities (p values were 0.357, 0.602 and 0.051, respectively). As a result, in order to clarify the resistance mechanisms of different genotypes of C.albicans isolates, more sophisticated and large-scale studies should be performed.

Özet

Son yıllarda özellikle çeşitli nedenlerle bağışıklık sistemi baskılanmış hastaların sayısındaki hızlı artış nedeniyle Candida albicans'm neden olduğu enfeksiyonların sıklığında artış olmuştur. 25S intron genotiplendirmesi ile C.albicans suşları, aktarılabilir grup-1 intron varlığına göre, A, B ve C olmak üzere üç genotipe ayrılmaktadır. Genotip A izolatlarının artmış flusitozin direnci ile ilişkili olduğu bilinmektedir. Bu çalışmanın amacı, klinik izolatlardan elde edilen C.albicans suşlarının 25S genotip dağılımlarının belirlenmesi ve genotipler ile antifungal duyarlılıkları arasında ilişki olup olmadığının araştırılmasıdır. Çalışmaya çeşitli klinik örneklerden izole edilen 70 adet C.albicans susu alınmıştır. Suşların tanımlanması ve antifungal duyarlılık testleri sırasıyla API ID 32C ve ATB Fungus 2 (bioMerieux, Fransa) sistemleri kullanılarak yapılmıştır. Suşlardan DNA ekstraksiyonunu takiben genotipleme için literatürde belirtildiği şekilde polimeraz zincir reaksiyonu (PCR) gerçekleştirilmiştir. Elde edilen PCR ürününün büyüklüğüne göre genotipler belirlenmiştir. Genotipler ile antifungal duyarlılık paternleri arasındaki ilişkinin araştırılmasında Pearson Khi kare testi ve Fisher's Exact test kullanılmıştır. Değerlendirilen 70 susun 35'i (%50) genotip A, dokuzu (%12.9) genotip B ve 26'sı (%37.1) genotip C olarak bulunmuştur. Nistatin, mikonazol ve ketokonazol duyarlılıklarının genotipler arasında istatistiksel olarak anlamlı fark gösterdiği tespit edilmiştir (p değerleri sırasıyla; 0.032, 0.035 ve 0.035). Bu farklardan genotip B suşları içerisinde orta derecede duyarlı (ve dirençli) izolat sayısının daha fazla olması sorumlu görülmektedir. Ancak, 25S intron varlığına göre antifungal duyarlılıklar değerlendirildiğinde, intron varlığı ile antifungal duyarlılıklar arasında istatistiksel olarak anlamlı bir ilişki tespit edilememiş ve genotiplerle flusitozin, amfoterisin B ve ekonazol duyarlılıkları arasında anlamlı fark bulunmamıştır (p değerleri sırasıyla; 0.357, 0.602 ve 0.051). Sonuç olarak, C.albicans genotipleri ile direnç gelişme mekanizmaları arasındaki olası ilişkinin altında yatan mekanizmaların aydınlatılabilmesi için daha geniş kapsamlı çalışmalara gereksinim vardır.

🔖

Cite This Article

BALABAN, N., KARAHAN, Z. C., MUMCUOĞLU, İ., ÇAYIRLI, A., KUŞTİMUR, S. (2007). Evaluation of the relationship between Candida albicans 25S intron genotypes and antifungal susceptibilities. Mikrobiyoloji Bülteni, Cilt: 41 - Sayı: 2, 245–251. https://ajindex.com/articles/299050

References (2)

  1. Verduyn Lunel FM, Meis JF, Voss A. Nosocomial fungal infections: candidemia. Diagn Microbiol Infect Dis 1999; 34: 213-20. 2.Dalle F, Franco N, Lopez J, et al. Comparative genotyping of Candida albicans bloodstream and nonbloodstream isolates at a polymorphic microsatellite locus. J Clin Microbiol 2000; 38: 4554-9. 3.Monod M, Borg von Zepelin M. Secreted proteinases and other virulence mechanisms of Candida albicans, pp: 114-28. In: Breitenbach M, Crameri R, Lehrer SB (eds), Füngal Allergy and Pathogenicity. 2002,
  2. Karger, Basel. 4.Pfaller MA. Epidemiology of fungal infections: the promise of molecular typing. Clin Infect Dis 1995; 20: 1535-9. 5.McCullough JM, demons KV, Stevens DA. Molecular and phenotypic characterization of genotypic Candida albicans subgroups and comparison with Candida dubliniensis and Candida stellatoidea. J Clin Microbiol 1999; 37: 417-21. 6.Soll DR. The ins and outs of DNA fingerprinting the infectious fungi. Clin Microbiol Rev 2000; 13: 332-70. 7.Scherer S, Stevens DA. Application of DNA typing methods to epidemiology and taxonomy of Candida species. J Clin Microbiol 1987; 25: 675-9. 8.Pujol C, Joly S, Lockhart SR, Noel S, Tibayrenc M, Soil DR. Parity among the randomly amplified polymorphic DNA method, multilocus enzyme electrophoresis, and southern blot hybridization with the moderately repetetive DNA probe Ca3 for fingerprinting Candida albicans. J Clin Microbiol 1997; 35: 2348-58. 9.Mercure S, Montplaisir S, Lemay G. Correlation between the presence of a self-splicing intron in the 25S rDNA of C.albicans and strains susceptibility to 5-fluorocytosine. Nucleic Acids Res 1993; 21: 6020-7. 10.Tamura M, Watanabe K, Mikami Y, Yazawa K, Nishimura K. Molecular characterization of new clinical isolates of Candida albicans and C.dubliniensis in Japan: Analysis reveals a new genotype of C.albicans with group I intron. J Clin Microbiol 2001; 39: 4309-15. 11.Richardson MD, Warnock DW (eds). Antifungal drugs, pp: 35-38. In: Fungal Infection. Diagnosis and Management. 2002, 2nd ed. Blackwell Science, UK. 12.McCullough MJ, Clemons KV, Stevens DA. Molecular epidemiology of the global and temporal diversity of Candida albicans. Clin Infect Dis 1999; 29: 1220-5. 13.Millar BC, Moore JE, Xu J, Walker MJ, Hedderwick S, McMullan R. Genotypic subgrouping of clinical isolates of Candida albicans and Candida dubliniensis by 25S intron analysis. Lett Appl Microbiol 2002; 35: 102-6. 14.Karahan ZC, Güriz H, Ağırbaşlı H, et al. Genotype distribution of Ca